Thank you Abbey for capturing the history of the Act's development so well. A thousand mile journey begins with a single step, and you have accomplished much beyond a thousand steps! I really enjoyed working with you to get what is still the only approved ALS therapy to market, and have learned much from you and the partnership together on that journey. 

Best always, 

Leo Adalbert

Formerly Marketing and Launch Team Leader

Rilutek (riluzole) for Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease)